新聞Terumo Cardiovascular Group is developing CAPIOX FX Oxygenators in Ashitaka.Terumo also will continue to produce CAPIOX FX Oxygenators in Ashitaka, Japan.
新聞Terumo Cardiovascular Group expands offices to Asia.Terumo began sales of the product in the U.S. and Europe, and will expand its sales coverage to Japan and Asia.
新聞Terumo Cardiovascular Group invests into assets: Perfusion Circuit Technology and Manufacturing Center in the amount of $42M.As a result, Terumo Cardiovascular is investing US $42 million in a new Perfusion Circuit Technology and Manufacturing Center in Costa Rica, the first plant of the cardiovascular division in Latin America.
